Search Results
Jul 30, 2026, 18:27 ET Illinois American Water Supports Water Utility Workforce Development to Build the Next Generation of Water Professionals
X and
More news about: American Water
Jul 30, 2026, 17:22 ET FUJIFILM GFX100RF: A 102 MP Point-and-Shoot Medium Format Camera; YouTube Video at B&H
GFX100RF packs all the quality and performance of its 102MP sensor and X Processor 5 into a sleek, lightweight, all-metal housing.
More news about: B&H Photo
Jul 30, 2026, 16:30 ET Smallest.ai gets $21 Million in Funding to Build Voice 4.0, the Next Generation of Enterprise Voice AI
redaction.Customers use Smallest.ai to automate enterprise voice workflows, reducing support costs by up to 80% while improving agent productivity by as much as 10x."Voice AI is creating a real impact on life and work," said Ashish Kakran, Managing Partner at Seligman Ventures. "Developers now increasingly
More news about: Smallest.ai
Jul 30, 2026, 16:30 ET MSA Safety Announces Second Quarter 2026 Results
while investing $13 million in capital expenditures. The company's net leverage ratio was 0.8x at quarter end. Including the debt for the acquisition of Autronica Fire and Security, pro forma net leverage is ~1.8x.Conference Call MSA Safety will host a conference call on Friday,
More news about: MSA Safety
Jul 30, 2026, 16:30 ET Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation
(viii) effect of competition in Corteva's industry; (ix) competitor's establishment of an intermediary platform for distribution of Corteva's products; (x) risks related to recent funding and staff reductions at U.S. government agencies; (xi) risk related to geopolitical and military conflict; (xii) effect
More news about: Corteva Agriscience
Jul 30, 2026, 16:30 ET QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2026 RESULTS
resulted in net debt of approximately $721.0 million. The Company's net debt divided by its trailing twelve months adjusted EBITDA was approximately 2.3x.In the second quarter of 2026, the Company announced a new share repurchase program authorizing the Company to repurchase up to an aggregate of
More news about: Quaker Chemical Corporation
Jul 30, 2026, 16:20 ET Huntsman Announces Third Quarter 2026 Common Dividend
www.huntsman.com.Social Media:X:
More news about: Huntsman Corporation
Jul 30, 2026, 16:15 ET Invesco Mortgage Capital Inc. Reports Second Quarter 2026 Financial Results
2026Economic return(3) of 3.8% compared to (3.2)% in Q1 2026Debt-to-equity ratio of 6.3x compared to 6.1x as of March 31, 2026Economic debt-to-equity ratio(1) of 7.5x, unchanged from March 31, 2026Update from Kevin Collins, Chief Executive
More news about: Invesco Mortgage Capital Inc.
Jul 30, 2026, 16:15 ET DXC Technology Reports First Quarter Fiscal Year 2027 Results
down 5.1% YoY, down 6.7% on an organic basis(1)Q1 FY27 Bookings of $3.0 billion, up 5% YoY with a book to bill ratio of 0.99xQ1 FY27 EBIT margin of 6.9%, and adjusted EBIT(2) margin of 5.0%Q1 FY27 Diluted earnings per share of $0.73;
More news about: DXC Technology Company
Jul 30, 2026, 16:15 ET CNO Financial Group Reports Second Quarter 2026 Results
incremental to normal spend and will not recur following implementation, net of taxes; (ix) goodwill and other asset impairment expenses, net of taxes; (x) gains or losses related to divested business, net of taxes; and (xi) other non-operating items including earnings attributable to variable interest entities,
More news about: CNO Financial Group
Jul 30, 2026, 16:15 ET Huntsman Announces Second Quarter 2026 Earnings
www.huntsman.com.Social Media:X:
More news about: Huntsman Corporation
Jul 30, 2026, 16:06 ET Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway
selinexor in combination with ruxolitinib compared to placebo plus ruxolitinib in JAKi-naïve myelofibrosis patients with platelet counts >100 x 109/L (N=353). Patients were randomized 2-to-1 to the selinexor arm. The co-primary endpoints for this trial are spleen volume reduction ≥
More news about: Karyopharm Therapeutics Inc.
Jul 30, 2026, 16:05 ET Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
performance, we are increasing our revenue and earnings guidance for the year," said Jacob Thaysen, Chief Executive Officer of Illumina. "Demand for NovaSeq X remains high as we expand our workflow and multiomics capabilities, broadening the value of Illumina's ecosystem."Fiscal year 2026 guidance
More news about: Illumina, Inc.
Jul 30, 2026, 16:05 ET Penumbra, Inc. Reports Second Quarter 2026 Financial Results
X. Forward-Looking StatementsExcept for historical information, certain statements in this press release are forward-looking
More news about: Penumbra, Inc.
Jul 30, 2026, 16:05 ET Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
LinkedIn and on X at @Karyopharm.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of The Private
More news about: Karyopharm Therapeutics Inc.
Jul 30, 2026, 16:05 ET Castle Biosciences Reports Second Quarter 2026 Results
X and
More news about: Castle Biosciences, Inc.
Jul 30, 2026, 16:05 ET GRAND CANYON EDUCATION, INC. REPORTS SECOND QUARTER 2026 RESULTS
investigations or otherwise; (ix) risks associated with changes in applicable federal and state laws and regulations and accrediting commission standards; (x) competition from other education service companies in our geographic region and market sector; (xi) our ability to hire and train new, and develop and
More news about: Grand Canyon Education, Inc.
Jul 30, 2026, 16:05 ET DIAMONDROCK HOSPITALITY COMPANY REPORTS SECOND QUARTER 2026 RESULTS
completed the sale of its leasehold interest in the 189-room Courtyard New York Manhattan/Fifth Avenue for $33.0 million. The sales price represents a 6.3x multiple on 2025 Hotel Adjusted EBITDA and a 13.3% capitalization rate on 2025 Hotel Net Operating Income. Inclusive of $12 million of capital expenditures
More news about: DiamondRock Hospitality Company
Jul 30, 2026, 16:01 ET STANDEX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2026 FINANCIAL RESULTS
1.8x2.6x1.9x
More news about: Standex International Corporation
Jul 30, 2026, 16:01 ET PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on LinkedIn, X, Facebook and Instagram.For more information please contact:Investors:Ellen Cavaleri+1 (615) 618-8228
More news about: PTC Therapeutics, Inc.
Jul 30, 2026, 16:01 ET Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results
debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)NEUROCRINE, the NEUROCRINE BIOSCIENCES Logo, YOU DESERVE BRAVE SCIENCE, INGREZZA,
More news about: Neurocrine Biosciences, Inc.
Jul 30, 2026, 16:00 ET FatPipe, Inc. (FATN) Reports Q1 FY2027 Results: 28% Y-o-Y Q1 Revenue Growth and 25.6% Adjusted EBITDA Margin
www.fatpipeinc.com.Follow us on X
More news about: FatPipe Networks
Jul 30, 2026, 16:00 ET Coveo Reports First Quarter Fiscal 2027 Financial Results
X, and
More news about: Coveo Solutions Inc.
Jul 30, 2026, 16:00 ET Coveo Reports First Quarter Fiscal 2027 Financial Results
X, and
More news about: Coveo Solutions Inc.